Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Dr David Stamler Biotech Showcase Presentation

January 8, 2018 Kerry Rowe

Prana Biotechnology JPM investor presentation_updated

Post navigation

Prana meeting with investors at world’s largest healthcare conference in San Francisco

PBT434 poster presented at the 6th International Multiple System Atrophy Conference

Related Posts

Prana Biotechnology Investor Presentation

June 27, 2018

Prana Doses First Patient in the “IMAGINE” Phase II Alzheimer’s Disease Trial

July 17, 2013

Prana Biotechnology Investor Presentation and Audio Recording – Phase 2 HD trial

February 18, 2014

Recent Posts

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
Alterity receives a $4.8 million R&D Tax Incentive Refund
European Commission approves Orphan Designation for Alterity’s lead drug candidate
Chairman’s Address to Shareholders 2019 Annual General Meeting
AGM 2019 Presentation

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News
Contact us

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065